[Federal Register Volume 72, Number 230 (Friday, November 30, 2007)]
[Notices]
[Pages 67736-67737]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-23183]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; Comment Request; Pretesting of NIAID's 
HIV Vaccine Research Communications Messages

SUMMARY: Under the provisions of section 3507(a)(1)(D) of the Paperwork 
Reduction Act of 1995, the National Institute of Allergy and Infectious 
Diseases (NIAID), the National Institutes of Health (NIH) has submitted 
to the Office of Management and Budget (OMB) a request to review and 
approve the information collection listed below. This proposed 
information collection was previously published in the Federal Register 
on August 28, 2007, page 49282 and allowed 60-days for public comment. 
One public comment was received and was addressed in the OMB request. 
The purpose of this notice is to allow an additional 30 days for public 
comment.
    Proposed Collection: Title: Pretesting of NIAID's HIV Vaccine 
Research Communications Messages. Type of Information Collection 
Request: NEW. Need and Use of Information Collection: This is a request 
for clearance to pretest messages, materials and program activities 
produced for the NIAID HIV Vaccine Research Education Initiative 
(NHVREI). The primary objectives of the pretests are to (1) assess 
audience knowledge, attitudes, behaviors and other characteristics for 
the planning/development of health messages, education products, 
communication strategies, and public information programs; and (2) 
pretest these health messages, products, strategies, and program 
components while they are in

[[Page 67737]]

developmental form to assess audience comprehension, reactions, and 
perceptions. The information obtained from audience research and 
pretesting results in more effective messages, materials, and 
programmatic strategies. By maximizing the effectiveness of these 
messages and strategies for reaching targeted audiences, the frequency 
with which publications, products, and programs need to be modified is 
reduced. Frequency of Response: On occasion. Affected Public: 
Individuals. Type of Respondents: Adults at risk for HIV/AIDS, 
particularly those who are Black/African-American, Hispanic/Latino, or 
men who have sex with men; healthcare providers; representatives of 
organizations disseminating HIV-related messages or materials. The 
annual reporting burden is shown in the table below. There are no 
Capital Costs to report. There are no Operating or Maintenance Costs to 
report.

----------------------------------------------------------------------------------------------------------------
                                                                    Estimated                       Estimated
                                                    Estimated       number of        Average       total annual
              Type of respondents                   number of     responses per   burden hours     burden hours
                                                   respondents     respondent     per response      requested
----------------------------------------------------------------------------------------------------------------
At-risk Adults.................................           3,374               1           .3422          1,155
Healthcare providers...........................              50               1           .75               37.5
Organization Gatekeepers.......................              75               1           .50               37.5
----------------------------------------------------------------------------------------------------------------
    Total......................................           3,499  ..............  ..............          1,230
----------------------------------------------------------------------------------------------------------------

    Request for Comments: Written comments and/or suggestions from the 
public and affected agencies should address one or more of the 
following points: (1) Evaluate whether the proposed collection of 
information is necessary for the proper performance of the function of 
the agency, including whether the information will have practical 
utility; (2) Evaluate the accuracy of the agency's estimate of the 
burden of the proposed collection of information, including the 
validity of the methodology and assumptions used; (3) Enhance the 
quality, utility, and clarity of the information to be collected; and 
(4) Minimize the burden of the collection of information on those who 
are to respond, including the use of appropriate automated, electronic, 
mechanical, or other technological collection techniques or other forms 
of information technology.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, New Executive Office Building, Room 10235, Washington, DC 
20503, Attention: Desk Officer for NIH. To request more information on 
the proposed project or to obtain a copy of the data collection plans 
and instruments, contact Katharine Kripke, Assistant Director, Vaccine 
Research Program, Division of AIDS, NIAID, NIH, 6700B Rockledge Dr., 
Bethesda, MD 20892-7628, or call non-toll-free number 301-402-0846, or 
E-mail your request, including your address to [email protected].
    Comments Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 30 days 
of the date of this publication.

    Dated: November 7, 2007.
John J. McGowan,
Deputy Director for Science Management NIAID.
 [FR Doc. E7-23183 Filed 11-29-07; 8:45 am]
BILLING CODE 4140-01-P